<DOC>
	<DOCNO>NCT00159640</DOCNO>
	<brief_summary>The purpose study determine effectiveness PD-217,014 treatment chronic pain follow shingle infection .</brief_summary>
	<brief_title>Placebo Controlled Dose-Response Study Of PD-217,014 In The Treatment Of Postherpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia , Postherpetic</mesh_term>
	<criteria>Patients must pain present 3 month heal shingle skin rash . Patients screen must score &gt; =40 mm pain visual analogue scale . Patients poor renal function . Patients severe pain , may impair selfassessment pain due shingle . Patients abnormal electrocardiogram .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
</DOC>